Results 101 to 110 of about 859,888 (229)

TRICUSPID REGURGITATION: NO LONGER THE ‘FORGOTTEN’ VALVE

European Medical Journal Cardiology, 2019
Considered initially as a bystander, tricuspid regurgitation has shown to be an important predictor of mortality in patients with left-side valvular or myocardial disease.
Livia Gheorghe, Benno JWM Rensing, Jan AS Van der Heyden, Bushra Rana, Martijn C Post, Martin J Swaans   +5 more
doaj  

Transcatheter Intervention Is Associated With Visceral Decongestion in Patients With Severe Tricuspid Regurgitation

Clinical Cardiology, Volume 49, Issue 10, October 2026.
Patients with severe symptomatic tricuspid regurgitation were assigned to transcatheter tricuspid valve intervention. Most patients showed discontinuous renal vein blood flow (arrows, Grade IV°) prior to TTVI (baseline). At follow‐up after 1 to 3 months, patients showed continuous renal vein blood flow profile (arrows, Grade I°) representing a marked ...
Franz Josef Putz, Johannes Spahn, Paul C. Kranert, Franziska Grewe, Moritz Haus, Michael Wester, Valeska Bienert, Maximilian Trum, Christian Schach, Andreas Luchner, Christoph Birner, Bernhard Unsöld, Miriam C. Banas, Bernhard Banas, Lars S. Maier, Kurt Debl, Michael Paulus, Christine Meindl   +17 more
wiley   +1 more source

Transcatheter Tricuspid Valve-In-Ring and Aortic Valve-In-Valve Implantation

, 2017
Background Transcatheter heart valve (THV) therapies have shown to be an alternative to surgical valve replacement, especially in high-risk patients requiring redo surgery.
Florian Deuschl, Andreas Schaefer, Hermann Reichenspurner, Ulrich Schaefer, Daniel Reichart, Niklas Schofer, Stefan Blankenberg, Lenard Conradi   +7 more
core   +1 more source

Transcatheter Tricuspid Valve Clinical Trials: Incomplete Data and FDA-Approved Devices

Structural Heart
Each reviewed trial of transcatheter tricuspid valve intervention demonstrated clinically meaningful improvement in Kansas City Cardiomyopathy Questionnaire (KCCQ)-defined quality of life and favorable right ventricular remodeling.
Deborah Furman, MD, Brian Whisenant, MD
doaj   +1 more source

Transcatheter Tricuspid Valve Replacement After Failed Transcatheter Annuloplasty and Edge-to-Edge Repair

JACC Case Reports
Background The EVOQUE transcatheter tricuspid heart valve (Edwards Lifesciences) is approved for high-risk patients with severe tricuspid regurgitation (TR).
Stefan Toggweiler, F. Moccetti, S. Stämpfli, M. Wolfrum   +3 more
semanticscholar   +1 more source

Diagnostic Performance of a Deep Learning Model Using Phonocardiogram and Single‐Lead ECG Signals for Detecting Moderate‐or‐Greater Aortic Stenosis: Multicenter External Validation

Clinical Cardiology, Volume 49, Issue 10, October 2026.
In an independent multicenter cohort of 951 patients undergoing echocardiography, a deep learning model analyzing an 8‐s heart sound and ECG recording detected moderate‐or‐greater aortic stenosis with 92.9% sensitivity and 87.9% specificity. This approach may support the decision to refer patients from auscultation to echocardiography.
Shumpei Saito, Masanobu Ishii, Shimpei Ogawa, Hiroshi Seki, Koshiro Ikeda, Youhei Kayano, Yuhei Yasui, Ginga Sato, Mitsuru Ohishi, Takuro Kubozono, Naritatsu Saito, Eri Toda Kato, Masahiro Yamada, Shunsuke Natori, Yuki Kunikane, Takafumi Yokomatsu, Masashi Kato, Yasuaki Sagara, Nami Uchiyama, Nobuhiko Atsuchi, Shota Kawahara, Shoji Natsugoe, Noriaki Tabata, Kenichi Tsujita   +23 more
wiley   +1 more source

Tricuspid valve surgery for acute infective endocarditis can be performed with very low operative mortalityCentral MessagePerspective

JTCVS Open
Objective: Tricuspid valve surgery historically has been perceived as having elevated operative risk, prompting the recent development of transcatheter therapies including aspiration vegetectomy for endocarditis.
Ali Darehzereshki, MD, J. Hunter Mehaffey, MD, MSc, J.W. Awori Hayanga, MD, MPH, Lawrence Wei, MD, Taylor D'etcheverry, PA-C, Luigi F. Lagazzi, MD, Vinay Badhwar, MD   +6 more
doaj   +1 more source

Standardized Reporting of Cardiac Magnetic Resonance Examinations in Children With Cardiac Diseases and Adults With Congenital Heart Disease: A Scientific Statement From the Association for European Pediatric and Congenital Cardiology (AEPC) and the International Society for Magnetic Resonance in Medicine (ISMRM)

Journal of Magnetic Resonance Imaging, EarlyView.
Francesca Raimondi, Inga Voges, Lamia Ait‐Ali, Sonya Babu‐Narayan, Rene Botnar, Barbara Burkhardt, Adrienne Campbell‐Washburn, Dominik Daniel Gabbert, Georg Hansmann, Willem A. Helbing, Hasan Hosan, Sylvia Krupickova, Heiner Latus, Duarte Martins, Colin McMahon, Christian Meierhofer, Vivek Muthurangu, Tiina Ojala, Pim van Ooij, Claudia Prieto, Milan Prsa, Kuberan Pushparajah, José F. Rodríguez Palomares, Samir Sarikouch, Lars Grosse‐Wortman, F. Gerald Greil, Heynric Grotenhuis   +26 more
wiley   +1 more source

Machine Learning‐Based Prediction of Mortality in Patients With Mitral Regurgitation: Results From Two Nationwide, Prospective Studies

MedComm, Volume 7, Issue 10, October 2026.
Using two nationwide prospective Chinese cohorts totaling nearly 11,000 patients with significant mitral regurgitation, we developed and externally validated a CatBoost‐based machine learning model for all‐cause mortality prediction. The model achieved AUCs of 0.783 internally and 0.703 externally, outperforming the Cox model, MitraScore, and EuroSCORE
Yuzhe Yin, Junxing Lv, Qinghao Zhao, Yunqing Ye, Weiwei Wang, Haitong Zhang, Zhenyan Zhao, Qingrong Liu, Zikai Yu, Bin Zhang, Shuai Guo, Zhenya Duan, Bincheng Wang, Yanyan Zhao, Runlin Gao, Zhe Li, Haiyan Xu, Yongjian Wu, Junbo Ge, for the CHINA‐VHD collaborators   +19 more
wiley   +1 more source

Outcomes of Transcatheter Tricuspid Valve-in-Valve Implantation in Patients With Ebstein Anomaly. [PDF]

, 2018
We sought to describe the acute results and short- to medium-term durability of transcatheter tricuspid valve-in-valve (TVIV) implantation within surgical bioprostheses among patients with Ebstein anomaly (EA).
Taggart, Nathaniel W, Thomas K. Jones, Boudjemline, Younes, Fagan, Thomas E, Brian Whisenant, Jeffery Meadows, Mary H. Martin, Delaney, Jeffrey W, Turner, Daniel R, John D.R. Thomson, Mark Hoyer, Eicken, Andreas, Younes Boudjemline, Schubert, Stephan, Jeremy D. Asnes, Frank F. Ing, Thomson, John D R, Foerster, Susan, McElhinney, Doff B, Stephan Windecker, Allison K. Cabalka, Shahanavaz, Shabana, James A. Kuo, Doff B. McElhinney, Matthew Gillespie, Aboulhosn, Jamil A, Jeffrey W. Delaney, Daniel R. Turner, Stephan Schubert, Whisenant, Brian, Daniel Dvir, Asnes, Jeremy D, Gillespie, Matthew, Ing, Frank F, Dvir, Daniel, Thomas E. Fagan, Eric Horlick, Gianfranco Butera, Martin L. Bocks, Bryan H. Goldstein, Kuo, James A, Aphrodite Tzifa, Hoyer, Mark, Bocks, Martin L, Shabana Shahanavaz, Tzifa, Aphrodite, Cabalka, Allison K, Windecker, Stephan, Latib, Azeem, Horlick, Eric, Azeem Latib, Susan Foerster, Goldstein, Bryan H, Meadows, Jeffery, Martin, Mary H, Butera, Gianfranco, Jones, Thomas K, Nathaniel W. Taggart, Andreas Eicken, Jamil A. Aboulhosn   +59 more
core   +1 more source